Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

MEDIA-Russian plant to produce first AstraZeneca vaccine batches in June - RBC

Wed, 12th May 2021 18:39

May 12 (Reuters) -

* Russian pharmaceutical firm R-Pharm will in June start
producing
the first doses in Russia of the COVID-19 vaccine developed by
AstraZeneca and Oxford University, RBC magazine reported
on Wednesday, citing the company's director Vasiliy Ignatiev.

* It will produce a few hundred thousand doses a month, RBC
cited
Ignatiev as saying.

* The company will be making doses exclusively for export,
not for
use in Russia, RBC reported. It will handle exports together
with the Russian Direct Investment Fund, the sovereign wealth
fund responsible for marketing the Russian-made Sputnik V
vaccine abroad.
-- Source link: https://www.rbc.ru/business/12/05/2021/609be9e09a794724e9305084?from=from_main_6
-- Note: Reuters has not verified this story and does not vouch
for its accuracy.
(Reporting by Moscow newsroom; editing by Philippa Fletcher)

Related Shares

More News
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump...

25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover ta...

25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln *

25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.